{"id":"https://openalex.org/W2324025629","doi":"https://doi.org/10.1158/1538-7445.am10-952","title":"Abstract 952: Nitric oxide donor sulindac inhibits photocarcinogenesis by modulating epithelial mesenchymal transition and mitogen activated protein kinase signaling in SKH-1 hairless mouse skin","display_name":"Abstract 952: Nitric oxide donor sulindac inhibits photocarcinogenesis by modulating epithelial mesenchymal transition and mitogen activated protein kinase signaling in SKH-1 hairless mouse skin","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2324025629","doi":"https://doi.org/10.1158/1538-7445.am10-952","mag":"2324025629"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-952","doi":"https://doi.org/10.1158/1538-7445.am10-952","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-952","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100784807","display_name":"Tripti Singh","orcid":"https://orcid.org/0000-0002-8855-3421","observed_orcids":["https://orcid.org/0000-0002-8855-3421"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tripti Singh","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077241246","display_name":"Puneet Kapur","orcid":"https://orcid.org/0000-0001-8821-9012","observed_orcids":["https://orcid.org/0000-0001-8821-9012"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puneet Kapur","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sandeep C. Chaudhary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep C. Chaudhary","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051982352","display_name":"Craig A. Elmets","orcid":"https://orcid.org/0000-0001-7131-4697","observed_orcids":["https://orcid.org/0000-0001-7131-4697"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Elmets","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051957313","display_name":"Levy Kopelovich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Levy Kopelovich","raw_affiliation_strings":["2National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079917691","display_name":"Mohammad Athar","orcid":"https://orcid.org/0000-0001-5829-7992","observed_orcids":["https://orcid.org/0000-0001-5829-7992"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammad Athar","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"952","last_page":"952"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.39480000734329224,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.08699999749660492,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitric-oxide-donors","display_name":"nitric oxide donors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/photocarcinogenesis","display_name":"photocarcinogenesis","score":0.7559999823570251},{"id":"https://openalex.org/keywords/uvb-induced-skin-cancer","display_name":"UVB-induced skin cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.925000011920929},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8360000252723694},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.859000027179718},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/bcl-2-bax","display_name":"Bcl-2/Bax","score":0.7229999899864197},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.7950000166893005},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.777999997138977},{"id":"https://openalex.org/keywords/jnk1-2","display_name":"JNK1/2","score":0.9049999713897705},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C2776241388","wikidata":"https://www.wikidata.org/wiki/Q963093","display_name":"Sulindac","level":3,"score":0.8989656567573547},{"id":"https://openalex.org/C2779156968","wikidata":"https://www.wikidata.org/wiki/Q17141495","display_name":"Hairless","level":2,"score":0.8434255123138428},{"id":"https://openalex.org/C76419328","wikidata":"https://www.wikidata.org/wiki/Q74419","display_name":"Epithelial\u2013mesenchymal transition","level":4,"score":0.6329001188278198},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5286614894866943},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5281277298927307},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5090464949607849},{"id":"https://openalex.org/C34688535","wikidata":"https://www.wikidata.org/wiki/Q418732","display_name":"Proliferating cell nuclear antigen","level":3,"score":0.44846874475479126},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.39833948016166687},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3972289562225342},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3299270272254944},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2768367826938629},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24368447065353394},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23981967568397522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18293258547782898},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10606321692466736},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.09501704573631287},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-952","doi":"https://doi.org/10.1158/1538-7445.am10-952","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-952","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076257784","https://openalex.org/W1969174403","https://openalex.org/W2146992529","https://openalex.org/W2134553513","https://openalex.org/W2168011206","https://openalex.org/W2296134791","https://openalex.org/W2032240165","https://openalex.org/W2044280607","https://openalex.org/W1979892584","https://openalex.org/W2792260120"],"abstract_inverted_index":{"Abstract":[0],"Nitric":[1],"oxide":[2],"(NO)-releasing":[3],"non-steroid":[4],"anti-inflammatory":[5],"drugs":[6],"(NO-NSAIDs)":[7],"have":[8,12,21],"been":[9],"shown":[10],"to":[11,185,223,227],"anti-proliferative,":[13],"proapoptotic":[14],"and":[15,83,100,119,161,169,213,264,270,286,300],"cancer":[16,31],"inhibitory":[17],"properties.":[18],"Here,":[19],"we":[20,188],"investigated":[22],"the":[23,94,106,135,149,167,175,180,202,216,228,296,316,321],"effects":[24,176],"of":[25,46,61,75,93,109,130,137,177,182,204,230,236,246,289,298,315,320],"NO-donor":[26],"sulindac":[27],"on":[28,91,179],"UVB-induced":[29,247],"skin":[30,144,269,271,305],"development":[32],"in":[33,66,128,140,143,166,266,304],"SKH-1":[34],"hairless":[35],"mice.":[36,133],"Mice":[37],"(6-8":[38],"weeks":[39],"old)":[40],"were":[41,125],"divided":[42],"into":[43],"three":[44],"groups":[45],"ten":[47],"mice":[48,82],"each,":[49],"which":[50],"received":[51],"either":[52],"vehicle":[53],"(acetone),":[54],"vehicle+UVB":[55],"(180mJ/cm":[56],"2)":[57],"or":[58],"topical":[59],"application":[60],"NO-sulindac":[62,70,131,138,178,200,239,278,292],"(5mg/mouse)+UVB":[63],"after":[64],"dissolving":[65],"acetone.":[67],"Mice-treated":[68],"with":[69,79,242,295],"developed":[71],"significantly":[72],"less":[73,88],"number":[74],"tumors":[76,129,145,168],"(60%)":[77],"compared":[78,226],"non-NO-sulindac":[80,231],"treated":[81,132,232],"tumor":[84,170],"volume":[85],"was":[86,221,240],"also":[87],"by":[89,148,238,291],"90%":[90],"termination":[92],"experiment":[95],"at":[96],"week":[97],"30th.":[98],"Immunohistochemical":[99],"western":[101],"blot":[102],"analyses":[103],"revealed":[104],"that":[105,277,287],"expression":[107,164,203,303],"levels":[108,165],"proliferation":[110],"markers":[111,206],"such":[112,207,251],"as":[113,146,208],"proliferating":[114],"cell":[115,120,191],"nuclear":[116],"antigen":[117],"(PCNA)":[118],"cycle":[121],"regulatory":[122],"cyclin":[123],"D1":[124],"markedly":[126],"diminished":[127],"However,":[134],"treatment":[136],"resulted":[139],"enhanced":[141,162],"apoptosis":[142],"ascertained":[147],"increased":[150,225],"terminal":[151,260],"deoxynucleotidyl":[152],"transferase-mediated":[153],"nick":[154],"end":[155],"labeling":[156],"(TUNEL)":[157],"assay,":[158],"reduced":[159],"Bcl-2":[160],"Bax":[163],"uninvolved":[171],"skin.":[172],"To":[173],"investigate":[174],"progression":[181],"benign":[183],"lesions":[184],"invasive":[186],"carcinomas,":[187],"examined":[189],"squamous":[190],"carcinomas":[192],"(SCC)":[193],"for":[194,284,324],"various":[195],"epithelial-mesenchymal":[196],"transition":[197],"(EMT)":[198],"markers.":[199],"decreased":[201],"mesenchymal":[205],"Fibronectin,":[209],"N-cadherin,":[210],"SNAI,":[211],"Slug":[212],"Twist":[214],"whereas":[215],"epithelial":[217],"polarity":[218],"marker":[219],"E-cadherin":[220],"found":[222],"be":[224],"SCCs":[229],"group.":[233],"Down":[234],"regulation":[235],"EMT":[237,299],"associated":[241,294],"a":[243,280],"remarkable":[244],"diminution":[245],"phosphorylation":[248],"MAPK":[249,301],"proteins":[250],"as,":[252],"extracellular":[253],"signal-regulated":[254],"kinase":[255,261],"1/2":[256,262],"(Erk":[257],"1/2),":[258],"c-Jun-NH2":[259],"(JNK1/2)":[263],"p38":[265],"both":[267],"UVB-exposed":[268],"tumors.":[272,306],"Together":[273],"our":[274],"results":[275],"suggest":[276],"is":[279,293],"potential":[281],"chemopreventive":[282],"agent":[283],"photocarcinogenesis":[285,290],"inhibition":[288,297],"protein":[302],"Citation":[307],"Format:":[308],"{Authors}.":[309],"{Abstract":[310],"title}":[311],"[abstract].":[312],"In:":[313],"Proceedings":[314],"101st":[317],"Annual":[318],"Meeting":[319],"American":[322],"Association":[323],"Cancer":[325,335],"Research;":[326],"2010":[327],"Apr":[328],"17-21;":[329],"Washington,":[330],"DC.":[331],"Philadelphia":[332],"(PA):":[333],"AACR;":[334],"Res":[336],"2010;70(8":[337],"Suppl):Abstract":[338],"nr":[339],"952.":[340]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}